RE:RE:The Ball is in THTX's CourtTHTX is not the only biotech with promising prospects they are hundreds of small companies out there, again if we look at how they market themselves the ones who are proactively reaching out to investors are valued much more than the rest.
For instance as mentioned earlier some have a section re partnership in their website and often they already have teamed up with bigger pharmas, it is a very competitive market and the investor relation is as important as the rest of company's operations.
"If you can't beat them join them" is what THTX have to do.
Paul moved from a well established company to relatively unknown small biotech so he needs to realize he can't apply the same strategy.
Once they pass the hurdle being noticed by the market then they have a big audience following every move they make rather than some few hundred on this board and Stocktwits, the trick is to pass that hurdle...